Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease

[1]  D. Miklavčič,et al.  Stimulation , 2020, Definitions.

[2]  V. Visser-Vandewalle,et al.  Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease , 2018, Neuromodulation : journal of the International Neuromodulation Society.

[3]  G. Fink,et al.  Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts , 2018, Brain Stimulation.

[4]  V. Visser-Vandewalle,et al.  Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease , 2018, Movement disorders : official journal of the Movement Disorder Society.

[5]  G. Fink,et al.  Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age , 2018, Movement disorders : official journal of the Movement Disorder Society.

[6]  Lars Timmermann,et al.  Directional DBS increases side‐effect thresholds—A prospective, double‐blind trial , 2017, Movement disorders : official journal of the Movement Disorder Society.

[7]  A. Machado,et al.  Predictors of Functional and Quality of Life Outcomes following Deep Brain Stimulation Surgery in Parkinson's Disease Patients: Disease, Patient, and Surgical Factors , 2017, Parkinson's disease.

[8]  M. Kurtis,et al.  The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence , 2017, npj Parkinson's Disease.

[9]  Jianmin Pan,et al.  ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves. , 2016, Surgery.

[10]  J. Zarranz,et al.  Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease , 2016, Journal of Neurology.

[11]  G. Fink,et al.  Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease , 2016, Brain Stimulation.

[12]  Brittany D. Walls,et al.  Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson’s Disease: A Meta-Analysis , 2015, Neuropsychology Review.

[13]  J. Felmlee,et al.  Motor and Nonmotor Circuitry Activation Induced by Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease: Intraoperative Functional Magnetic Resonance Imaging for Deep Brain Stimulation. , 2015, Mayo Clinic proceedings.

[14]  P. Svenningsson,et al.  EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[15]  T. R. Schneider,et al.  Subthalamic deep brain stimulation improves auditory sensory gating deficit in Parkinson’s disease , 2015, Clinical Neurophysiology.

[16]  S. Cooper,et al.  Predicting quality of life outcomes after subthalamic nucleus deep brain stimulation , 2014, Neurology.

[17]  E. Fonoff,et al.  Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease , 2014, Neurology.

[18]  Beth A. Parente,et al.  Effect of advancing age on outcomes of deep brain stimulation for Parkinson disease. , 2014, JAMA neurology.

[19]  P. Krack,et al.  Mechanisms of Body Weight Fluctuations in Parkinson’s Disease , 2014, Front. Neurol..

[20]  John C. Rothwell,et al.  Pathophysiology of somatosensory abnormalities in Parkinson disease , 2013, Nature Reviews Neurology.

[21]  L. Timmermann,et al.  Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  H. Reichmann,et al.  Nonmotor fluctuations in Parkinson disease , 2013, Neurology.

[23]  I. Forgacs,et al.  Intrajejunal Levodopa Versus Conventional Therapy in Parkinson Disease: Motor and Nonmotor Effects , 2012, Clinical neuropharmacology.

[24]  Gabriele Schackert,et al.  Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease. , 2012, Parkinsonism & related disorders.

[25]  R. Sakakibara,et al.  Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. , 2012, Brain : a journal of neurology.

[26]  G. Deuschl,et al.  Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable? , 2011, Movement disorders : official journal of the Movement Disorder Society.

[27]  J. Marinus,et al.  SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease. , 2011, Parkinsonism & related disorders.

[28]  K. Chaudhuri,et al.  The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[29]  L. Schöls,et al.  CSF Aβ42 and tau in Parkinson's disease with cognitive impairment , 2010, Movement disorders : official journal of the Movement Disorder Society.

[30]  Z. Kefalopoulou,et al.  Effects of subthalamic nucleus deep brain stimulation on sweating function in Parkinson's disease , 2010, Clinical Neurology and Neurosurgery.

[31]  M Zappia,et al.  International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease , 2009, Neurology.

[32]  B. Schmand,et al.  Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  Carmen Rodriguez-Blazquez,et al.  Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[34]  Gereon R Fink,et al.  Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation. , 2007, Brain : a journal of neurology.

[35]  Paolo Barone,et al.  The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study , 2007, Movement disorders : official journal of the Movement Disorder Society.

[36]  P. Derost,et al.  Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. , 2007, Brain : a journal of neurology.

[37]  Sara Marceglia,et al.  Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation , 2007, Movement disorders : official journal of the Movement Disorder Society.

[38]  G. Deuschl,et al.  A randomized trial of deep-brain stimulation for Parkinson's disease. , 2006, The New England journal of medicine.

[39]  Paolo Barone,et al.  International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[40]  Rajesh Pahwa,et al.  Deep brain stimulation: Preoperative issues , 2006, Movement disorders : official journal of the Movement Disorder Society.

[41]  J. Benito-León,et al.  The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure. , 2005, Journal of clinical epidemiology.

[42]  A M Stiggelbout,et al.  A short scale for the assessment of motor impairments and disabilities in Parkinson’s disease: the SPES/SCOPA , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[43]  K. Østergaard,et al.  Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus , 2004, Movement disorders : official journal of the Movement Disorder Society.

[44]  A. Benabid,et al.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.

[45]  C. Mariani,et al.  Body weight gain rate in patients with Parkinson's disease and deep brain stimulation , 2003, Movement disorders : official journal of the Movement Disorder Society.

[46]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[47]  E. Tolosa,et al.  Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation , 2002, Journal of neurology, neurosurgery, and psychiatry.

[48]  R. Fitzpatrick,et al.  The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. , 1997, Age and ageing.

[49]  A. Stone,et al.  Preoperative Issues , 2019, Complications in Orthopaedics: Sports Medicine.

[50]  R. Fitzpatrick,et al.  The PDQ-8: Development and validation of a short-form parkinson's disease questionnaire , 1997 .